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436a Tuesday, February 28, 2012sarcomere function with consequences for in vivo cardiac performance. The
functional role of cMyBP-C is tightly regulated by kinase-mediated phosphor-
ylation, of which protein kinase A (PKA)-mediated phosphorylation is impor-
tant during cardiac stress and exercise. To date, three serines have been
identified on which cMyBP-C can be phosphorylated in vivo, all of which
are located in the cardiac isoform specific M region, i.e. Ser273, Ser282 and
Ser 302. However, previous experiments have indicated that at least one
more phosphorylation site should exist in humans. The aim of the present study
was to identify the unknown phosphorylation site on human cMyBP-C.
cMyBP-C was semi-purified from human non-failing donor and end-stage fail-
ing cardiac tissue. Tandem mass spectrometry was used to identify phosphor-
ylation sites. Besides the already known Ser282 site, a phosphorylation site was
detected on Ser133 in donor tissue. For characterization of this site, a phospho-
specific antibody was developed. Levels of Ser133 phosphorylation are lower
in end-stage heart failure samples as well as in samples from hypertrophic
and dilated cardiomyopathy patients compared to donor. Initial experiments
suggest that unlike the three previously known phosphorylation sites, Ser133
is not phosphorylated by PKA.
In conclusion, we identified a fourth phosphorylation site (Ser133) in human
cMyBP-C, which is present in the Pro-Ala rich region that links the C0 and
C1 domains. This site is less phosphorylated in various cardiac pathologies
and does not seem to be a target of PKA.
Supported by the 7th Framework Program of the European Union (‘‘BIG-
HEART,’’ grant agreement 241577).
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Cardiac myosin binding protein-C (cMyBP-C), a sarcomeric protein with 11
domains- C0-C10, binds myosin LMM via its C-terminus, while its N-terminus
binds both myosin S2 and actin. These N-terminal interactions can be attenu-
ated by phosphorylation of serines within the C1-C2 linker. In vivo, cMyBP-
C exists in a range of phosphorylation states, which may alter its regulation
of actomyosin. Therefore, N-terminal fragments (C0-C3) of cMyBP-C were
bacterially expressed with one or more phosphorylatable serines (S273,
S282, S302) mutated to either alanines to mimic dephosphorylation or
aspartic acids as phosphomimetics. Using C0-C3 fragments that were effec-
tively mono-, di- or tri-phosphorylated, we characterized how the extent of
cMyBP-C phosphorylation modulated the the force:velocity relationship gener-
ated by a small ensemble (~8 motors) of skeletal muscle myosin in the load-
clamped laser trap assay. Mono-phosphorylated C0-C3 inhibited unloaded
velocity by 70% as did unphosphorylated C0-C3, while di- and tri-
phosphorylated constructs were indistinguishable and less inhibitory (30%).
Maximal force was unaffected by the extent of phosphorylation. Thus, the
un- and mono-phosphorylated C0-C3 constructs depressed the force-velocity
relationship, which was well fitted by a modified Hill equation containing an
assumed viscous load due to C0-C3 binding to actin (Weith et al., 2011). In
addition, both un- and mono- phosphorylated C0-C3 reduced peak power by
~40%, while neither di- nor tri-phosphorylated C0-C3 had any effect on peak
power. cMyBP-C phosphorylation appears to modulate cMyBP-C’s inhibition
of actomyosin power generation in an ‘‘on/off’’ manner.
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Enhanced cardiac contractility results from phosphorylation within the
cMyBP-C motif domain by affecting the interaction of cMyBP-C’s N-terminus
with actin and/or myosin. We investigated whether motif (i.e. C1C2 linker)
phosphorylation alters its structural conformation by characterizing the force-
extension behavior of expressed N-terminal cMyBP-C fragments (i.e.C0C3)
that contain the motif using atomic force spectroscopy. Proteins were adsorbed
onto glass slides, bound non-specifically to SiNi AFM probes, and stretched at
700nm/s. Force-extension traces showed the characteristic sawtooth shape of
unfolding immunoglobulin domains, and were well fitted by the wormlike
chain model. The model fits produced a median persistence length of 0.36nm
and an average C0C3 contour length of 71.5nm, suggesting that the motif is dis-ordered and freely extensible when unphosphorylated. PKA phosphorylation
did not change immunoglobulin unfolding force or persistence length but de-
creased the contour length by 27nm, suggesting that the motif assumed a folded
configuration that is stable under load. This was investigated further by varying
the extent of phosphorylation using phosphomimetic mutants, in which serines
273, 282, and 302 were replaced with different combinations of alanines or as-
partic acids in order to mimic the unphosphorylated and phosphorylated states
respectively. While substitution with all alanines or all aspartic acids produced
similar results to the control and PKA treated fragments respectively, phos-
phorylation at only one or two sites did not reduce contour length significantly.
This implies that phosphorylation at all three sites is required for motif folding
to be stable under load, while partial phosphorylation may result in a fold which
is readily extended at low force. In conclusion, cMyBP-C phosphorylation
could modulate the cMyBP-C’s N-terminal domain interactions with actin
and/or myosin by folding the motif in such a way that binding sites for actin
and/or myosin are hidden.
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Titin is a giant protein that functions as a molecular spring and contributes to
the passive diastolic stiffness of the left ventricle (LV). Titin’s spring region
consists of three sequence elements: the tandem Ig, the N2B and the PEVK el-
ements. Mouse models exist in which either of the latter two elements (N2B
KO, PEVK KO) has been deleted, but considering that these elements are
also likely to play roles in signaling, we made a model in which we deleted
2/3 of the proximal tandem Ig element (IGKO), a region that is not known to
contain signaling functions. Homozygous KO mice survive to adulthood and
are fertile with no change in LV Weight to Body Weight (LVW/BW) ratio
(3.6750.07mg/g WT vs 3.5150.04mg/g IgKO). A custom titin exon microar-
ray confirmed the deletion of the expected exons with no other changes. Gel
electrophoresis showed that the IGKO expresses an 88kDa smaller titin isoform
but no other changes in isoform expression. Immuno-electron microscopy indi-
cates that the remaining spring elements extend to a higher degree than in WT
myocardium. Mechanical measurements in cardiomyocytes (see also poster by
Methawasin) and myofibers show that the deletion increases passive stiffness in
titin in a sarcomere length dependence manner, without adaptations in the pas-
sive stiffness of the extracellular matrix. Initial isolated intact heart data and
in-vivo pressure volume measurement suggest that the IGKO has increased
stiffness in-vivo. Further phenotypic characterization is currently underway.
In summary, shortening the proximal tandem Ig element of titin produces a
diastolic stiffness phenotype.Platform: Mitochondria in Cell Life & Death
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Tubulin has been recently identified as a powerful regulator of voltage depen-
dent anion channel (VDAC). Dimeric tubulin induces reversible blockage of
VDAC reconstituted into planar lipid membranes and blocks the flux of
ATP/ADP across the mitochondrial outer membrane. Here we show that phos-
phorylation of VDAC by cytosolic kinases protein kinase A (PKA) and glyco-
gen synthase kinase-3b (GSK3b) increases the on-rate of tubulin binding by
orders of magnitude, but only for tubulin at the cis (or cytosolic) side of the
membrane. This and the fact that the basic properties of VDAC, such as
single-channel conductance and selectivity, remained unaltered by phosphory-
lation allowed us to suggest the phosphorylation regions positioned on the
cytosolic loops of VDAC and establish channel orientation in our reconstitution
experiments. Experiments on human hepatoma cells HepG2 are in agreement
with our findings that phosphorylation state of VDAC determines its blockage
by tubulin. When HepG2 cells were treated with the microtubule-destabilizing
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as measured by tetramethylrhodamine methyester (TMRM) uptake, decreased.
Inhibition of PKA activity with H89 increased mitochondrial potential and, fur-
thermore, reversed mitochondrial depolarization induced by colchicine. To fur-
ther explore a role VDAC-tubulin interaction in cell proliferation and survival,
we studied the effect of erastin, the selective anti-tumour agent involved in the
RAS-RAF-MEK signalling pathway, on VDAC blockage by tubulin. We found
that erastin reverses tubulin blockage of VDAC isolated from HepG2 cells, pro-
moting the unblocked state of the channel. Our findings suggest a novel func-
tional link between serine/threonine kinase signalling pathways, mitochondrial
respiration, and highly dynamic microtubule network which is characteristic of
carcinogenesis and cell proliferation.
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VDAC proteins represent a main component of the outer mitochondrial mem-
brane (OMM). The VDAC family is composed of 3 isoforms with more than 70
percent similarity. Although their primary role was known to be in ion and me-
tabolite transport between mitochnodria and cytosol, it has been discovered that
VDACs are involved in apoptotic pathways. We have recently found that spe-
cifically the VDAC2 isoform is needed for tBid-induced cytochrome c release,
due to its role in supporting Bak insertion to the OMM (Roy et al.2009. EMBO
Rep.10:1341-7). Sequence analysis of the mammalian VDAC isoforms shows
a unique N terminal end in VDAC2, which is likely to be exposed to the cyto-
plasm. To test the functional significance of this N terminus, the first 12 amino
acids were removed from VDAC2 or were added to VDAC1. VDAC2-/- MEF
cells that are resistant to tBid, were rescued with these constructs and cyto-
chrome c release was monitored in permeabilized cells by single cell imaging
and immunoblotting. These studies revealed that cytochrome c release upon
tBid application is effectively supported by both full length VDAC2 and the
VDAC2 N-terminal deletion mutant. Furthermore, VDAC1 extended by the
N terminus of VDAC2 failed to restore cytochrome c release in VDAC2-/-
MEFs. Thus the N terminus of VDAC2 seems to be dispensible for tBid-
induced OMM permeabilization. Currently, we are designing different muta-
tions which target some addititional unique sequences in VDAC2 to find the
specific domain that is essential for tBid induced cytochrome c release.
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The mitochondrial Ca2þ uptake has been recognized as a central player in cel-
lular pathophysiology for decades. Pathways of Ca2þ transport across the inner
mitochondrial membrane (IMM) were investigated indirectly with biochemical
techniques and most recently by applying the patch clamp technique to mito-
plasts isolated from mammalian systems. Patch-clamp recording of the IMM
have proved to provide an unambiguous picture of mitochondrial Ca2þ uptake
under strictly controlled conditions.
In this study, we evaluated and compared the biophysical properties of mito-
chondrial Ca2þ uptake in different mouse tissues. Freshly isolated mitoplasts
from mouse heart, skeletal muscle, liver, kidney, spleen and brown adipose tis-
sue were patch clamped in the whole-mitoplast configuration. Voltage step and
ramp protocols covering the whole range of physiological potentials were ap-
plied to elicit the inwardly rectifying Ca2þcurrent sensitive to RuR known as
MCU. The distribution of MCU current densities between tissues was as fol-
lows: spleen > brown adipose tissuez skeletal muscle > kidney > liver >>
heart. Interestingly, MCU current density in heart was about 10 times smaller
than in skeletal muscle. Our results support the view of a differential tissue
activity of MCU, which can be explained by either a different distribution of
MCU channel and/or by a different expression of its regulatory subunits confer-
ing various modes of physiological regulation.
Further on, in order to investigate the putative direct contribution of Uncou-
pling Protein Isoform 2 and 3 (UCP2/3) to the uniporter, we investigated
MCU properties in wild type (WT) mouse tissues where these two proteins
have been found to have a major role and compared its properties in the corre-
spondent tissues of UCP2 and UCP3 KO mice. We found no significant differ-
ences in calcium currents of any of the WT tissues studied compared to their
UCP2/3 KO counterparts.2218-Plat
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Chronic alcoholism causes various forms of stress in the heart, and this is often
accompanied by mitochondrial dysfunction. A putative source of mitochondrial
dysfunction is SR-mitochondrial stress and the ensuing mitochondrial Ca2þ
overload. To test this possibility, first we isolated mitochondria from chronic
ethanol-fed (6 months) and paired control rats, and documented ethanol-
dependent sensitization to Ca2þ and ROS-induced permeabilization. To evalu-
ate the ultrastructural basis of the mitochondrial impairments, we performed
transmission electron microscopy (TEM) and electron tomography studies of
left ventricular muscle. The overall ultrastructure of the myocytes became
less organized in the ethanol-fed condition. Also, a considerable fraction of
the mitochondria lost the highly ordered structure of the cristae and showed
an increase in the cross-sectional area. However, the size of the SR-
mitochondrial associations and the gap-width at the interface was unchanged.
Evaluation of the SR-mitochondrial tethers by electron tomography indicates
that they occur in clusters and display heterogeneity in length, as previously re-
ported for ER-mitochondrial tethers in normal rat liver (Csordas et al, 2006, J
Cell Biol, 174:915). Overall tether length distribution appears to be unaltered
by alcohol ingestion. Analyses of effects of alcohol ingestion on tether
membrane-surface density and structural classes (linear, V, Y and more com-
plex shapes) is in progress, as is 3D analysis of SER and mitochondrial inner-
and outer-membrane topologies. (Supported by NIH grant 1RC2AA019416.)
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We report that, in non-apoptotic pro-lymphocyte cells, Bcl-xL induced an in-
crease of the mitochondrial localization of Bax up to the level found in apopto-
tic cells. Furthermore Bcl-xL stimulated both the active conformation of Bax
and increased the total amount of Bax inserted in the outer mitochondrial mem-
brane. In order to further investigate the molecular mechanisms involved in this
effect, different Bax and Bcl-xL mutants were co-expressed in yeast. We found
that wild-type Bcl-xL increased the mitochondrial localization of both wild-
type Bax and of an active mutant Bax-S184D, while mutant Bcl-xL-G138A
did not have this effect. Further, wild-type Bcl-xL protected Bax-S184D
against proteolytic degradation. Finally, we found that a C-terminally truncated
mutant of Bcl-xL, that lost its capacity to inhibit Bax-induced release of cyto-
chrome c, still increased the mitochondrial localization of wild-type Bax, thus
promoting the release of cytochrome c. These data suggest that Bcl-xL, by act-
ing as a modulator of mitochondrial Bax localization, may play an active role
along the pathway leading to Bax activation.
2220-Plat
The Physiological Response of Intact Ex VivoMitochondria upon Apopto-
tic Stress: Insight into the Regulation of Apoptosis at a Mitochondrial
Level
Martin N. Lidman1, Marcus Wallgren1, Olivier Keech2, Yong-Zhi Guo3,
Tor Ny3, Gerhard Gro¨bner1.
1Chemistry Department, Umea˚ University, Umea˚, Sweden, 2Umea˚ Plant
Science Center, Umea˚, Sweden, 3Medical Chemistry and Biophysics, Umea˚
University, Umea˚, Sweden.
Apoptosis - programmed cell death - is vital for multicellular organisms to dis-
pose of redundant, damaged or infected cells. This mechanism becomes dys-
functional in cancer where tumor cells survive drug-induced death signals.
Reversely, upregulated apoptosis can induce premature neuronal cell death
in amyloidogenic diseases such as Alzheimer’s disease (AD) or Amyotrophic
Lateral Sclerosis (ALS). Mitochondrion, the power plant of the cell, contains
an arsenal of proteins which regulate programmed cell death. There, the pro-
and anti-apoptotic Bcl-2 proteins meet at the mitochondrial membrane to
decide the fate of a cell. How the molecular activities of the anti-apoptotic
